HONG KONG, May 13, 2026 - (ACN Newswire) - The sixth Asia Summit on Global Health (ASGH), jointly organised by the Government of the Hong Kong Special Administrative Region and the Hong Kong Trade Development Council (HKTDC), and the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), organised by the HKTDC and co-organised by the Hong Kong MedTech Association, have concluded successfully. As one of the two flagship events of International Healthcare Week, the ASGH gathered some 3,000 participants from 43 countries and regions and arranged over 400 one‑on‑one deal-making meetings, while also facilitating the signing of multiple cooperation agreements, with a strong focus on the application of artificial intelligence. Meanwhile, the Medical Fair welcomed some 13,000 buyers from 61 countries and regions for sourcing and networking. More than 670 business matching meetings were arranged during the fair, supporting buyers and exhibitors in identifying potential partners and advancing concrete business discussions. Together, the two flagship events facilitated over 1,000 high-quality collaborations and connections, fully demonstrating the synergy between medical technology, investment and industry applications.

Over 90 global leaders share insight into healthcare innovation development and AI applications

The sixth ASGH, a two-day event jointly organised by the Government of the Hong Kong Special Administrative Region and the HKTDC, has concluded under the theme Fuelling Healthcare Breakthroughs, focusing on public health, frontier healthcare technologies, AI breakthroughs, healthcare investment and the silver health. The ASGH brought together over 90 international healthcare officials, scientific pioneers, Nobel laureate, investors and corporate leaders to share insight and explore pathways to accelerate innovation across the global healthcare ecosystem.

At Plenary Session I – Strengthening Pandemic Preparedness through Global Collaboration. Prof Ibrahim Abubakar, Vice‑Provost (Health) and Professor of Infectious Disease Epidemiology, University College London, said: “Research platforms need to be developed long in advance of pandemics, and we must invest in infectious disease infrastructure, and beyond, whether it’s in AI technology or in  disease management.”

Plenary Session II – Fuelling Healthcare Breakthroughs centred on the commercialisation of medical research, biomedical innovation and healthcare investment opportunities. Jonathan Symonds, Chair of GSK, said: “All developed countries are now facing ageing, low birth rates and an increasing impact of chronic disease. So, it's no longer just a health system problem, but it's now an economic problem.”

During the Dialogue with Global Pioneer in Health session, Prof Michael Levitt, 2013 Nobel Laureate in Chemistry and Robert W and Vivian K Cahill Professor of Cancer Research at the Stanford University School of Medicine, said that Hong Kong’s healthcare system possesses unique advantages and high-quality statistical data, making it potentially more valuable for research than the US and other countries or regions, in  areas such as longevity.

The ASGH featured multiple thematic sessions spotlighting the application of AI in healthcare. Sustaining the momentum of the “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution” session on the first day, another thematic session on the second day, “Transforming Healthcare through Digital Health & AI Innovations”, explored how digital technologies and artificial intelligence are reshaping healthcare systems. Natasha Chhatrapati, Senior Director, Business Transformation Lead for International, Pfizer Inc., said: “AI is compressing timelines across the entire healthcare journey, from drug development and clinical research to how we engage with physicians and how patients consume care.”

The session “The Next Frontier in China’s Healthcare Industry” examined strategies to advance the Chinese Mainland healthcare sector. Dr James Xue, Founder, Chairman and CEO of CANbridge Pharmaceuticals Inc, said: “China has an edge because of the population. A bigger population base will allow companies to build better drug candidates.”

With silver health emerging as a major global focus, the Silver Health Chapter included the session “Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations”, which brought together leading experts to discuss challenges and opportunities arising from population ageing. Dr Alex Mihailidis, Associate Vice‑President, International Partnerships and Professor at the University of Toronto and Scientific Director at AGE‑WELL, provided in‑depth insight into breakthroughs in prevention and treatment of age‑related diseases, offering guidance for the development of the silver health economy and smart ageing solutions. He said: “For a technology to be successful with older people, it’s not just the technology, but also the service delivery model, as well as the practice and policy.”

The newly introduced session “CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health” featured discussions on research strategy and the acceleration of scientific discoveries into practical applications. Dr Li Xiang, Senior Vice President, Co-President and Chief Scientific Officer, Innovative Medicines Division, Fosun Pharma, said: “In our business, it is very important to begin with the end in mind. When you set out to do your discovery program, you must already know what the unmet needs are and how difficult the clinical trials will be.”

Over 400 deal‑making sessions drive investment and business matching

Beyond thought leadership, the ASGH continued to serve as an effective platform for deal‑making and investment matching. Dedicated deal-making at the ASGH facilitated one‑to‑one meetings to promote tangible collaboration.

During the ASGH, over 400 business and investment matching meetings were arranged, attracting investment institutions and healthcare enterprises from Europe, the US, Asia and the Guangdong‑Hong Kong‑Macao Greater Bay Area to explore opportunities in investment, technology deployment and market expansion.

Colin Tan, Director of Operations at TusPark Holdings, an investor from the UK, said: “This year, I brought around 15 UK healthcare and life sciences companies to exhibit at the UK Pavilion. The ASGH has been an excellent platform to forge such connections. We are now facilitating a significant partnership in cancer research between a leading UK organisation and a Hong Kong counterpart.”

ASGH also featured the ASGH Business Hub and the InnoHealth Showcase, bringing together some 180 healthcare innovation companies from 12 countries and regions to present cutting‑edge solutions across biotechnology, digital health and medical technologies.

Strategic Partner of this year’s Summit, Shanghai Industrial Investment (Holdings) led multiple subsidiaries in exhibiting at the ASGH. Gu Feng, Chief Finance and Investment Officer, said that the ASGH fully showcased Hong Kong’s international competitiveness: “Chinese companies expanding overseas will come to Hong Kong, and foreign companies seeking to procure will do the same. Here we can not only acquire resources, but also connect and match resources, talent, capital, and other key elements.”

AQ Biotech from Finland, exhibiting at ASGH for the first time, said that their objective was to explore the Asian market. They view Hong Kong as a vital hub that adds internationally recognised credibility, connectivity and commercial acumen, helping them take their work global.

Dr Iman Manavitehrani, Founder and Director of SDIP Innovations, the Australian exhibitor returning for the second year, said: “Last year’s visit led directly to an IGNITE grant from HSITP, and we are now part of the first Australian cohort based here. With Hong Kong as our gateway to the GBA and Chinese Mainland, I am confident the connections made at the ASGH will lead to further collaboration and partnership.”

Third-time exhibitor, Prof Leung Kam-tong, Founder and CEO of local healthcare startup Homing Pharmaceuticals, said: “We’ve already reconnected with three investors here for in-depth discussions on our fundraising strategy, taking our navigated CAR-T therapy to first-in-human clinical trials. Sessions outside my field sparked new ideas around refining the therapy and exploring new directions. I also met professors from Australia and Singapore, and look forward to exploring international R&D collaborations as we bring this therapy worldwide.”

Building bridges for “go global” and other cross‑border healthcare collaborations

Building on its track record of facilitating collaboration, the ASGH enabled the signing of 10 Memoranda of Understanding (MoUs), such as those between the HKSH Medical Group and Siemens Healthineers, as well as Australian AI-powered clinical documentation platform startup Heidi Health, which signed separate agreements with local medical group EC Healthcare and Hong Kong Metropolitan University. These collaborations will drive deeper cooperation, including AI‑enabled healthcare applications and clinical research, further reinforced the ASGH’s role as a bridge connecting the Chinese Mainland and international healthcare ecosystems. Notably, HKSH Medical Group and Siemens Healthineers signed an agreement, formally establishing HKSH as Siemens Healthineers’ first Photon Counting Computed Tomography Simulation (PCCT-Sim) Reference Site in Asia.

On the second day, the GoGlobal CONNECT series: Hong Kong as a Superconnector to Empower Global Expansion of Pharmaceutical Enterprises workshop brought together experts in regulation, clinical trials, IP protection and distribution to share practical insight on international expansion. Prof Bernard Cheung, Chief Executive Officer, Greater Bay Area International Clinical Trial Institute, said: “Public hospitals in Hong Kong have very good electronic medical records that go back 30 years. It’s a unique asset that benefits not just people in Hong Kong but the world, as it allows us to study the long-term progression of diseases.”

The ASGH also featured the “GoGlobal Connect” and the Business of Healthcare Advisory Zone, enabling healthcare enterprises to connect with service providers and receive practical support for developing “go global” strategies. Xiang Jun, Chairman of 365 Intelligence (Beijing) Medical Technology Co., Ltd, said that the ASGH helped them gain a deeper understanding of Hong Kong’s professional services and of HKTDC’s “GoGlobal Connect” initiative. The company is particularly interested in Hong Kong’s research data and service resources, and plans to establish research operations in Hong Kong in the long term. Mark Xu, Regional Director of Sales and Marketing, Guangzhou Wondfo Biotech Co, Ltd, also successfully connected with service providers, including DKSH and the Greater Bay Area International Clinical Trial Institute, through this workshop. They engaged in in-depth discussions on potential collaboration opportunities for “going global”.

During the summit, the HKTDC signed a Memorandum of Understanding with the Hong Kong Singapore Business Association (HSBA), supporting Mainland enterprises’ “going global” via Hong Kong to target the Singapore and ASEAN markets. Prime Minister and Minister for Finance of Singapore Lawrence Wong visited Hong Kong in March this year, during which both governments agreed to deepen cooperation. The HSBA and the HKTDC, together with professional service providers, plan to strengthen trade and economic ties between the two cities. By leveraging their respective strengths and promoting complementary cooperation, they aim to drive business development, assist Chinese Mainland enterprises in expanding regionally and internationally, and enhance tripartite collaboration among Singapore, Hong Kong, and the Chinese Mainland.

The Medical Fair brings together global industry players to foster diverse collaborations, strengthening Hong Kong’s status as a global healthcare hub

The Medical Fair was being held concurrently. Organised by the HKTDC and co-organised by the Hong Kong MedTech Association, the Medical Fair adopted the theme Innovations Boosting Smart Health Experience. Focusing on three key areas: MedTech, GeronTech, and Preventive Healthcare, the event provided a high-efficiency trade and matchmaking platform for global R&D institutions, manufacturers, and medical professionals to showcase the latest industry trends. The number of exhibitors featuring smart ageing products and green solutions doubled this year, with many showcasing innovative solutions integrating AI and robotics to meet evolving market demands.

The Medical Fair featured some 300 exhibitors from 10 countries and regions, including Hong Kong, Chinese Mainland, Macao, Taiwan, Australia, Canada, Korea, New Zealand, United States and Vietnam. The Fair featured seven major zones, including Startup Zone, Hospital Equipment and Digital Health, Biotech and Lab Diagnostics, Laboratory Technologies and Healthcare Services, Medical Supplies, and the World of Health and Wellness, showcasing the latest medical technologies and innovative solutions. Pavilions from leading local universities, the Hong Kong Science and Technology Parks, and the Hong Kong MedTech Association underscored a multi-sector commitment to fostering collaborative innovation across government, industry, academia, research, and investment sectors.

Exhibitors acknowledged that AI has become a core driver of healthcare services, while the Medical Fair serves as a one-stop platform that brings together a complete healthcare ecosystem, successfully integrating AI, robotics technology and a wide range of smart medical devices. Wong Cheung Hang, Sales and Marketing Manager of Health Care & Co, a medical and rehabilitation equipment company in Hong Kong, said, “Buyers showed particular interest in our AI management systems, AI-assisted robots and various smart healthcare applications. With healthcare providers increasingly adopting smart health solutions, the market outlook is promising. We expect this fair to drive at least 20% business growth compared with last edition and enable us to promote smart rehabilitation technologies.”  Many overseas exhibitors succeeded in securing business matching opportunities at the fair. Peter Li, Chief Executive Officer of first-time exhibitor GenomeMe Lab Inc from Canada, said, “We connected with buyers from Hong Kong, Thailand and India, and identified potential local partners in the healthcare and hospital sectors. This will help us explore entry into hospital channels, establish distribution networks, and lay the groundwork for future expansion into Southeast Asia, Australia and Korea.”

The Medical Fair has facilitated numerous cross-regional collaborations, serving as a key platform for industry exchange and business matching. Dresio Limited, participating in the Fair for the third time under the banner of Hong Kong Science and Technology Parks, showcased its contactless physiotherapy assessment system Accudex, drawing strong interest from buyers across Hong Kong, Chinese Mainland, Singapore and the Philippines. Curtis Wong, Chief Operating Officer and Head of Research and Development of the company, said, “This year’s fair outperformed previous editions in footfall, business exchanges and partnership discussions. We have engaged with a large number of high-quality buyers from hospitals, rehabilitation centres and the insurance sector.” The company met with a Filipino buyer on the first day of the exhibition and subsequently signed a Memorandum of Understanding (MOU) on the third day, expanding its software into Southeast Asia, with the contract value expected to exceed HK$1 million.

The Medical Fair was held concurrently with the ASGH and the Hospital Authority (HA) Convention, bringing together key industry stakeholders and generating strong synergy. Exhibitors were able to seize the opportunity to meet with numerous representatives from the Hospital Authority and major healthcare institutions, fostering meaningful exchanges and collaboration. Among them, first-time exhibitor PalmX Technology Limited showcased its palm vein biometric technology at the Startup Zone. Jeffrey Lo, Vice President of the company, was impressed by the Fair’s response, which exceeded his expectations. He added that within the first two days, they received over 20 enquiries from hospitals and healthcare institutions, including representatives from the Hospital Authority, and attracted interest from overseas buyers in Thailand, Indonesia, the Philippines and India, with potential orders ranging from US$10,000 to several hundred thousand dollars.

This year’s Medical Fair attracted a significant number of buyers from emerging markets seeking sourcing opportunities. Dr Keo Sovann, an otorhinolaryngologist from Orchid Hospital in Cambodia who visited the fair specifically for new medical equipment, said, “I met more than 10 exhibitors from Chinese Mainland, Australia and Malaysia, which has helped expanding our hospital’s procurement network and advanced our internationalization efforts. I am particularly interested in a Hong Kong company’s AI-powered medical imaging solutions and X-ray equipment; we are considering an order of 20 units.” A buyer from Morocco also attended the fair for the first time to source laboratory equipment. Rachid Zemmouri, Business Development Manager of Promamec, said he met with at least 15 exhibitors from Hong Kong, Chinese Mainland, Taiwan and Indonesia. Discussions are underway on thermodynamics-related solutions with the aim of application to eye-disease treatment. Subject to satisfactory progress, he plans to invite partners to Morocco for site visits. He added that the company has an annual procurement budget of approximately US$70 million and intends to return for future sourcing.

The Fair hosted over 50 themed forums and seminars, with leading technology companies, industry experts and academics sharing the latest industry trends, technological innovations and practical insights to foster in-depth exchange, collaboration and inspire trade buyers. Highlight sessions included “Accelerating Mental Health Innovation through AI Research and Adoption”, “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, “The ASEAN Gateway: Navigating Regulations, Capital and Distributions from Hong Kong”, and “Decoding the Demand for Gerontechnology” among others, all of which attracted strong audience engagement. Selected sessions are available for replay on the Fair’s website for extended engagement.

The exhibition continued to adopt the EXHIBITION+ hybrid model. Global exhibitors, industry professionals, and buyers could make use of the Click2Match and explore sourcing opportunities via HKTDC Sourcing. Click2Match will remain available until 20 May.

Photo download: https://bit.ly/4nokRfT

Websites

International Healthcare Week: https://internationalhealthcareweek.hktdc.com/en

Asia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en

Hong Kong International Medical and Healthcare Fair: 
https://www.hktdc.com/event/hkmedicalfair/en

List of Product: https://www.hktdc.com/event/hkmedicalfair/en/product  

Media enquiries

Yuan Tung Financial Relations:

HKTDC’s Communications & Public Affairs Department:

About HKTDC

The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. 

ORLANDO, FL, May 13, 2026 - (ACN Newswire) - At SAP Sapphire in 2026, SAP SE (NYSE: SAP) introduced the Autonomous Enterprise to help enhance the world’s most critical business workflows, so that humans and AI work together to meet the accelerating demands of global business profitably, strategically and safely. 

“For the mission-critical processes of our customers, ‘almost right’ just isn’t good enough,” said Christian Klein, CEO of SAP SE. “By uniting SAP Business AI Platform with SAP Autonomous Suite, we anchor AI agents in the business processes, data and governance so they can deliver accurate, compliant and secure outcomes, unlocking new sources of revenue and meaningful cost savings.”

The Autonomous Enterprise includes a unified AI platform for building, contextualizing and governing agents, an autonomous suite that executes core business operations and a new user experience that redefines how people work with enterprise software.

Introducing SAP Business AI Platform

SAP Business AI Platform is a new foundation for building and deploying enterprise AI grounded in real business context. SAP Business AI Platform now unifies SAP Business Technology Platform, SAP Business Data Cloud and SAP Business AI into a single, governed environment.

At its core is the SAP Knowledge Graph solution, which gives AI agents a structured map of business entities, processes and relationships across a customer’s SAP landscape. Joule Studio is SAP’s AI-first solution for building enterprise agents, applications and agentic workflows. Developers can build using the no-code, pro-code and AI frameworks of their choice on SAP-managed infrastructure that is secure, scalable and optimized for enterprise AI.

Deploying SAP Autonomous Suite Across Every Business Function and Industry

Building on this foundation, SAP also introduced SAP Autonomous Suite, which enables SAP’s existing business applications with AI agents capable of running processes from start-to-finish.

The suite will deploy more than 50 domain-specific Joule Assistants across finance, supply chain, procurement, human capital management and customer experience. These assistants will automate end-to-end processes by orchestrating a subset of over 200 specialized agents to execute precise tasks. For example, the new Autonomous Close Assistant can compress the financial close process from weeks to days by automating journal entries, reconciliation and error resolution across the entire process.

SAP also launched Industry AI, expanding its deep industry portfolio through seven autonomous solutions that will enable start-to-finish industry processes and embed sector-specific process logic, data models and regulatory requirements. At SAP Sapphire, SAP showcased its work with European energy giant RWE to leverage Industry AI, helping reduce unplanned downtime across its offshore wind turbines. With SAP’s Autonomous Asset Management scenario, AI agents are designed to analyze data from thousands of past incidents, identify the likely root cause and generate pre-filled work orders with the right tools and proven fixes from other sites.

Designing the Autonomous User Experience

The company also revealed Joule Work, redefining how users engage with SAP software. Instead of navigating individual applications and entering data across several screens, users will now interact primarily with Joule. By describing a desired business outcome, Joule will orchestrate the right combination of workflows, data and agents to get it done.

Joule Work goes beyond conversation, proactively surfacing relevant insights and automating routine tasks behind the scenes so work moves forward even when humans aren’t actively steering it. It will be available on desktop, mobile and voice across SAP and non-SAP systems.

Accelerating the Customer Journey Toward Autonomy with €100 Million Infusion

SAP evolved its customer and partner programs to help accelerate the organization’s journey to the Autonomous Enterprise. To catalyze adoption, the company has launched a €100 million fund for SAP partners to help customers deploy SAP-built AI assistants and agents. The fund is also available to partners that extend or build new partner agents on the new SAP Business AI Platform using Joule Studio.

SAP has enhanced its RISE with SAP and SAP GROW offerings to accelerate AI adoption. Both include access to the Joule Assistants portfolio; RISE with SAP customers will have three assistants activated within their first year, while SAP GROW customers receive full portfolio access at onboarding. SAP S/4HANA on-premises and SAP ERP Central Component (SAP ECC) customers are not excluded: those that commit to transitioning the majority of their current landscape to SAP Cloud ERP gain access to select AI scenarios, bridging the gap between their current landscape and their cloud destination

SAP also introduced new agent-led transformation tooling that can reduce ERP migration efforts by more than 35 percent, driving faster and more predictable projects by automating system analysis, code remediation, configuration and testing at scale.

Lastly, SAP announced a full slate of strategic partnerships across each category:

- Platform and suite partnerships include Anthropic, with Claude among the foundation models SAP’s AI platform will leverage to power Joule agents across HR, procurement and supply chain; Amazon Web Services, bringing zero-copy data integration between SAP Business Data Cloud and Amazon Athena; Google Cloud and Microsoft, enabling bidirectional agent-to-agent interoperability between Joule and external agent frameworks; Mistral AI and Cohere, delivering sovereign model options on SAP’s cloud infrastructure; n8n, providing visual AI workflow orchestration inside Joule Studio; NVIDIA, whose OpenShell provides the trusted secure runtime for Joule Studio; and Parloa, bringing AI agents into SAP Service Cloud to handle customer interactions with full access to business data and service processes.

- Implementation partnerships include Palantir and Accenture, partnering on complex data migration scenarios, and Conduct for AI-powered cloud ERP migrations.

Learn more in the SAP Sapphire 2026 Innovation News Guide.

Visit the SAP News Center. Get SAP news via LinkedIn and Bluesky.

Photo download: https://bit.ly/42zNb5h

About SAP

As a global leader in enterprise applications and Business AI, SAP (NYSE: SAP) stands at the nexus of business and technology. For over 50 years, organizations have trusted SAP to bring out their best by uniting business-critical operations spanning finance, procurement, HR, supply chain, and customer experience. For more information, visit www.sap.com/hk.

For more information, press only:

Strategic Public Relations Group (SPRG)

Andico Tsui
Email: andico.tsui@sprg.com.hk
Tel: 2114 4346 / 6902 3831

MUMBAI, INDIA, May 12, 2026 - (ACN Newswire) - CleverTap, the all-in-one customer engagement platform, has won Silver at the Thailand MarTech Awards 2026 in the Impact MarTech category, in partnership with Rabbit Rewards, the loyalty and lifestyle platform for Bangkok’s BTS Skytrain and a widely used commuter ecosystem in Southeast Asia.

The recognition highlights how CleverTap and Rabbit Rewards have transformed customer engagement by building a real-time, agentic engagement model powered by autonomous decisioning, designed to serve millions of commuters in a high-frequency environment.

Rabbit Rewards operates at the intersection of daily commuting, payments, and lifestyle services, where user behavior shifts constantly based on routine, timing, and location. Traditional campaign-led approaches, built on static segmentation and fixed schedules, were unable to keep pace and often resulted in delayed or irrelevant engagement.

To address this, Rabbit Rewards partnered with CleverTap to implement a real-time decisioning layer that continuously interprets live behavior and determines the next best action for each user.

With CleverAI™, and its suite of tools — including IntelliNODE and Best Time Optimization among others — Rabbit Rewards deployed trigger-based, omnichannel journeys across push notifications, in-app messaging, email, and SMS. These journeys span onboarding, renewals, promotions, and re-engagement, and adapt continuously to commuter behavior.

The shift to real-time, behavior-led engagement delivered clear, measurable outcomes:

• 85% uplift in click-through rates (CTR)
• 62.6% week-4 repeat transactions among engaged users, compared to 18.7% for non-engaged users
• 2.4% of total transactions directly influenced by CleverTap-powered engagement

Beyond these results, Rabbit Rewards significantly improved the quality of customer engagement. Communication became more timely, contextual, and aligned with commuter needs, strengthening trust and positioning the platform as a more intuitive, lifestyle-oriented companion for daily users.

“Our vision has always been to make everyday commuting more seamless, rewarding, and relevant for our users. Through our partnership with CleverTap, we have successfully transitioned from traditional campaign execution to a real-time engagement model that understands and responds to commuter behavior in the moment.

CleverAI™ has enabled us to deliver more personalized and timely experiences at scale, strengthening both customer engagement and long-term loyalty. This collaboration goes beyond technology — it is about ensuring Rabbit Rewards shows up for our members in ways that feel personal, timely, and genuinely useful throughout their daily journeys,” said Kamolwan Korphaisarn, Program Director, Rabbit Rewards

“Enterprises today sit on a surplus of data, but turning those data points into timely, meaningful action remains a big challenge. With CleverAI™, we’re enabling brands to move beyond static campaigns to intelligent systems that continuously interpret behavior, determine the next best action, and deliver truly personalized experiences in real time. Our work with Rabbit Rewards shows how this approach drives stronger engagement while enabling seamless, context-aware customer journeys at the scale of the individual,” said Anand Jain, Co-founder and Chief Marketing Officer, CleverTap.

About Rabbit Rewards

Rabbit Rewards is Thailand’s leading loyalty and lifestyle platform built around Bangkok’s BTS Skytrain ecosystem, one of Southeast Asia’s busiest urban transit networks serving millions of daily commuters.

The platform connects commuting, payments, and everyday lifestyle experiences into a single ecosystem, enabling members to access rewards, offers, and partner benefits across Bangkok.

As part of BTS Group Holdings, Rabbit Rewards serves a diverse member base ranging from daily riders and students to tourists and lifestyle-focused members, making it a deeply embedded companion in Bangkok’s urban lifestyle.

Rabbit Rewards continues to evolve its customer engagement capabilities to deliver more contextual, real-time experiences that align with the rhythm of everyday commuting and lifestyle needs.

For more information, visit rabbitrewards.co.th

About CleverTap

CleverTap is the world’s leading AI-first, all-in-one customer engagement and retention platform, helping brands turn data into lasting customer relationships. Powered by its proprietary CleverAI™: Decisioning Engine and Agentic AI-verse, CleverTap enables organizations to maximize customer lifetime value at scale. Its unified platform brings together AI-powered segmentation, personalization, experimentation, journey orchestration, and deep analytics—seamlessly integrated with 100+ leading martech solutions.

Leading brands such as Burger King, Levi’s, IKEA, Decathlon, Domino’s, Jio, Carousell, AIA Thailand, Sasom, 12Go, and Ngern Tid Lor,  rely on CleverTap to drive measurable growth through meaningful customer engagement. With backing from global investors including Accel, Peak XV Partners, Tiger Global, CDPQ, and 360 One, CleverTap has presence across  US, Europe, the Middle East, Latin America, and Asia.

For more information, visit clevertap.com or follow us on:

LinkedIn: https://www.linkedin.com/company/clevertap/
X: https://twitter.com/CleverTap

For more information:
ADITYA SANYAL
Director, Digital Marketing, CleverTap
+91 9177110080
aditya.sanyal@clevertap.com

ASHMIT CHAUDHARY
Associate Consultant, Archetype
+91 8850752121
ashmit.chaudhary@archetype.co

HONG KONG, May 11, 2026 - (ACN Newswire) - The fifth International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), opens today, featuring two flagship events. The sixth Asia Summit on Global Health (ASGH) is being held today and tomorrow (11 and 12 May) at the Hong Kong Convention and Exhibition Centre (HKCEC) under the theme “Fuelling Healthcare Breakthroughs”. The summit convenes over 90 influential international healthcare officials, research and medical experts, start-ups, investors, and business leaders from related industries to explore global healthcare trends, with a focus on frontier technologies, AI breakthroughs, pandemic preparedness, silver health, as well as innovation in Chinese medicine, in alignment with the National 15th Five-Year Plan. Another flagship event, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), also opens today (11 to 13 May) under the theme “Innovations Boosting Smart Health Experience”, featuring some 300 exhibitors from 10 countries and regions. The Fair spotlights MedTech, GeronTech and Preventive Healthcare, showcasing the latest medical innovations integrating artificial intelligence and robotics, fostering global exchange in healthcare innovation and reinforcing Hong Kong’s strengths as a research and commercial hub.

Prof Frederick Ma, Chairman of the HKTDC, said in his welcome remarks: “There is nowhere better than Hong Kong, as a major international hub for financing and innovation, to explore areas of global collaboration in the health arena, and to showcase related business opportunities for investors and project owners. As a superconnector and super value-adder, Hong Kong has a long track record of helping companies and innovations break through. The theme we have adopted this year, ‘Fuelling Healthcare Breakthroughs’, highlights this vital role. The ASGH was created to nurture partnerships and knowledge exchange that can drive real change and create a better world. This year’s agenda also complements the healthcare priorities set out in China’s new 15th Five-Year Plan, supporting national development. Among the diverse topics at ASGH 2026 are sessions examining AI-enabled diagnosis and treatment, biomedical innovation, the growth of the silver health economy, traditional Chinese medicine and much more.”

John Lee, Chief Executive of the HKSAR, said in his opening remarks: “Hong Kong, under the ‘one country, two systems’ principle, is investing in healthcare and, in doing so, investing in the future of our people and our economy. Our status as a leading hub for scientific innovation is unrivalled in Asia. And our strengths are magnified by our core position in the Guangdong-Hong Kong-Macao Greater Bay Area. That is the cluster city development integrating 11 dynamic cities in southern China. It boasts a collective economy that rivals that of the world's 10th-largest nation. In pursuit of medical innovation, Hong Kong complements the strategies set out in the National 15th Five-Year Plan. The Plan optimises an evaluation and approval mechanism for innovative drugs and supports their clinical application. The goal is to develop Hong Kong into a health and medical innovation hub. Central to this ambition is the rapid expansion of our clinical trial capabilities, the vital engine that drives biomedical R&D from the laboratory to the bedside.”

Prof Zeng Yixin, Vice Minister of the National Health Commission of the People’s Republic of China, delivered special remarks: “Hong Kong has extensive experience in undergraduate medical education and post-graduate training, and enjoys a strong reputation in the Asia-Pacific region. Medical talent training system on the mainland is also undergoing deep reforms and striving to move towards high-quality development. Hong Kong has many experiences and practices that are worthy of in-depth exchange and reference, which will certainly promote mutual enhancement and progress.”

Global leaders convene to explore collaboration opportunities

This morning’s Plenary Session I: Strengthening Pandemic Preparedness through Global Collaboration, featured keynote speech by Prof Lo Chung-mau, Secretary for Health of the HKSAR government, who said: “Hong Kong has long been recognised for the quality and efficiency of our healthcare system. We consistently rank at the top of global health indices, with a life expectancy that remains among the highest in the world, with women over 88 years and men about 83 years in 2024. Our public healthcare system serves as a robust safety net, ensuring universal health coverage for all at a very low cost. The National 15th Five-Year Plan calls for a health-first development strategy. Hong Kong is fully aligned and will continue to contribute to this national vision through our work in pandemic preparedness and medical innovation.”

Prof Leo Poon, Daniel C K Yu Professor in Virology at the School of Public Health of the University of Hong Kong and Co-Director of the Hong Kong Jockey Club Global Health Institute, moderated the session. Distinguished speakers included Prof Ibrahim Abubakar, Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London; Feng Lan, Vice President, China Pharmaceutical Innovation and Research Development Association; Dr Leung Yiu-hong, Head of Emergency Response and Programme Management Branch, Department of Health of the HKSAR government; Dr Kumanan Rasanathan, Executive Director of the WHO Alliance for Health Policy and Systems Research; Prof Wang Yu, Chairman of the Chinese Foundation for Hepatitis Prevention and Control, also Former Director-General, Chinese Centre for Disease Control and Prevention; and Dr In-Kyu Yoon, Deputy Director General for Integrated Development and Pandemic Preparedness at the International Vaccine Institute. They discussed key strategies to strengthen the resilience of the global health system in response to future pandemics. Dr Kumanan Rasanathan said: “Public health agencies need to maintain scientific independence to synthesize, act upon, and provide advice based on the best available science. They also require operational flexibility because, during a pandemic or outbreak, it is not sufficient to rely solely on strategies used for previous outbreaks.”

Plenary Session II: Fuelling Healthcare Breakthroughs was moderated by Victor Chu, Chairman and CEO of First Eastern Investment Group. Speakers included Clara Chan, CEO of Hong Kong Investment Corporation Limited; David Lau, Vice Chair of Investment Banking for Asia Pacific and Head of Healthcare Investment Banking for Asia Pacific at JP Morgan Securities; Dr Inna Menkova, Chief Executive Officer, Allogenica; Jonathan Symonds, Chairman of the Board of GSK; and Theresa Tse, Chairwoman of the Board, Sino Biopharmaceutical Limited; They examined investment trends and market transformation in biopharmaceuticals and explored how cross-sector collaboration can drive healthcare breakthroughs.

One of the highlights this afternoon, the Dialogue with Global Pioneer in Health session, featured 2013 Nobel Prize laureate in Chemistry, Prof Michael Levitt, Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University. He shared insights into his research and the future of technology-driven healthcare innovation, exploring how biological intelligence is shaping the future of healthcare. He said: “One of the secrets of successful evolution is to be as diverse as possible. This diversity then leads to intelligence.”

Thematic sessions spotlight cutting-edge healthcare innovation and AI applications

As the global healthcare industry accelerates towards technology-driven transformation and industrial upgrading, multiple thematic sessions at the summit focus on the application of innovative technologies across the sector. Topics include AI-enabled healthcare, medical robotics and devices, cell and gene therapies, biomedical, and the silver economy, showcasing the latest market trends and aligning with the National 15th Five-Year Plan to advance the development of a “Healthy China” and foster AI and healthcare innovation. The first day featured a dedicated session, The Next Frontier in China's Healthcare Industry, moderated by Nisa Leung, Managing Partner of Aulis Capital, with speakers including Mark Gavin Lotter, Founder and CEO of Nuance Pharma; Wu Hao, Executive Director and Co-President of Tigermed; and Seth Zhang, Founder and CEO of MediTrust Health. They discussed strategies to drive the development of the Chinese Mainland healthcare sector. Wu Hao said: “By giving China-led industry data and applications greater exposure and participation on the global stage, Chinese enterprises can take a seat at the table and become true leaders.”

Several thematic sessions spotlight the large-scale application of AI in healthcare. These include this afternoon’s sessions: Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution, moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, featured speakers including Prof Joshua Ho, Assistant Dean (Innovation and Technology Transfer) in the Li Ka Shing Faculty of Medicine at the University of Hong Kong; and Reshaping Tomorrow’s Healthcare: Advances in Medical Robotics and Devices, further explored the transformative role of AI in medical robotics and next-generation medical devices, showcasing cutting-edge innovations and breakthrough developments. Tomorrow afternoon’s session, Transforming Healthcare through Digital Health & AI Innovations, with speakers from Healthtech Finland, Heidi Health, Pfizer, The Hong Kong Polytechnic University and other leading organisations, will offer multi-dimensional insight into AI applications and breakthroughs in the healthcare field.

A new session this year, CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health, will bring together leading scientists from global pharmaceutical companies, including Dr Li Xiang, Senior Vice President, Co-President and Chief Scientific Officer of Innovative Medicines Division at Fosun Pharma, to discuss transforming research breakthroughs into real-world healthcare applications.

Building on last year’s Silver Health Chapter, tomorrow will feature the session Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations. Speakers include Prof Christopher Chao, Vice President (Research and Innovation) of the Hong Kong Polytechnic University; Prof Brian Kennedy, Director of the Centre for Healthy Longevity at the National University Health System, Singapore; and Zhang Junjie, Vice President of Ant Group and President of Healthcare Business Group. They will share insights into ageing-related disease prevention and solutions.

Other sessions also cover a wide range of cutting-edge topics, including Driving Chinese Medicine Development Through Standardisation and Innovation, and IP Financing and Trading for Pharmaceutical and Health Technology. These thematic sessions examine the latest developments and trends in the healthcare industry from multiple perspectives, promoting exchanges among scientific research, market applications and industry policy. During the session From Detection to Cure: Accelerating Innovations for Rare Diseases, Prof Liang Zicai, Founder and Chairman of Suzhou Ribo Life Science, will explore how innovative diagnostics and treatments are bringing new hope to patients. Another session, Charting the Future: A New Era in Gene and Cell Therapies, brought together Dr Li Xiang, Founder and CEO of XellSmart, and Dr Zhu Tian, Co-founder and CEO of GenEditBio, who shared the latest advancements in stem cell biology and genome editing platforms with other guests.    

A global platform for healthcare resource matching, empowering pharmaceutical and healthcare companies to expand their business

In addition to symposium sessions, some 180 healthtech companies from 12 countries and regions are showcasing innovative projects and solutions at the ASGH Business Hub and InnoHealth Showcase. At the same time, Project Pitching provides start-ups with opportunities to connect with investors, while the ASGH Deal-making facilitate one-on-one meetings to match global capital with healthcare projects. Participants can also access professional advice at the “GoGlobal Connect” and Business of Healthcare Advisory Zone, enabling companies to develop more targeted strategies for business expansion.

Medical Fair showcases diverse AI-driven health solutions, with smart ageing products surge twofold

The 17th Hong Kong International Medical and Healthcare Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, opened alongside ASGH. With the theme Innovations Boosting Smart Health Experience, the Fair brings together some 300 exhibitors from 10 countries and regions, including Hong Kong, the Chinese Mainland, Taiwan, Korea, as well as new participants from Macao, Australia, Canada, New Zealand, Vietnam and the United States, highlighting Hong Kong’s strengths as an international medical innovation hub.

The Fair focuses on three key areas: MedTech, GeronTech and Preventive Healthcare, presenting a comprehensive showcase of the latest medical and healthcare equipment, products and application solutions from around the world. For MedTech, Neuroptek Corporation Inc from Canadian pavilion (Booth No.: 3E-D16) showcases the brand new EyeMirage, a solution that extends professional ophthalmic vision examinations beyond the clinic. By leveraging the computing power and camera technology of smartphones, the system enables users to conduct high-quality vision tests in settings such as homes and schools. Meanwhile, HKG epiTherapeutics Limited (Booth number: 3E-E06), from the Hong Kong Science and Technology Parks, presents a DNA methylation analysis technology designed for the early screening of liver cancer. The solution can identify and distinguish differential methylation features among liver cancer, blood and normal tissues. Its clinical research findings have been published in leading international academic journals[1], demonstrating a sensitivity of 88.5% for early-stage liver cancer and 95.7% for late-stage cases, representing one of the highest performance levels globally in methylation-based liver cancer early screening.

In the field of GeronTech, the exhibits span a wide range of products, including smart rehabilitation robots, AI-powered mental health assessment systems, smart elderly care solutions and home-based care devices, fully addressing the evolving market needs of the silver economy. Hanshin Technology Limited (Booth No.: 3E-D13) introduces a Smart Shower Robot, which enhances safety and comfort for the elderly during bathing through intelligent design, while also easing caregivers’ workload and supporting the practical adoption of smart care solutions. Notably, the number of smart ageing products exhibited this year has more than doubled compared with the last edition, underscoring strong and growing market demand.

In Preventive Healthcare, an exhibitor from Chinese Mainland, Guangzhou Supbio Bio-Technology and Science Co., Ltd. (Booth No: 3E-E19), presents the world’s first HIV-1 DNA quantitative testing kit approved for market launch by the National Medical Products Administration (NMPA). Designed to address increasingly complex HIV testing needs, the solution provides a stable and reliable full-disease-course testing approach, supporting an integrated and innovative model that spans prevention, treatment efficacy assessment and the exploration of functional cure through precision diagnostics.

The Medical Fair features more than 50 themed forums and seminars, including topics such as “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, co-organised with the Hong Kong MedTech Association, to be held tomorrow morning (12 May), followed by the afternoon session “ASEAN Gateway: Navigating Regulations, Capital and Distributions from Hong Kong”. On Wednesday (13 May), sessions such as “Decoding the Demand for Gerontechnology” will also take place. Industry experts will share the latest insights and market trends, and the exhibition will provide an ideal platform for professionals to network and explore new business opportunities. 

The exhibition will continue to adopt the “EXHIBITION+” hybrid model. The physical fair will take place from 11 to 13 May at the HKCEC. Global exhibitors, industry professionals, and buyers can engage in discussions via the “Click2Match” smart business matching platform from 4 May until 20 May.

Photo download: https://bit.ly/4tsy9Js

Websites

International Healthcare Week: https://internationalhealthcareweek.hktdc.com/en

The Asia Summit on Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en?ref_source=GrayMenu&ref_medium=vep-conference

Hong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en?ref_source=GrayMenu&ref_medium=vep-tradeshow

List of Product: https://www.hktdc.com/event/hkmedicalfair/en/product?ref_source=GrayMenu&ref_medium=vep-tradeshow

Media enquiries

Yuan Tung Financial Relations:

Jasmine Zhang      Tel: (852) 3428 3278   Email: jzhang@yuantung.com.hk

Louise Song        Tel: (852) 3428 5691   Email: lsong@yuantung.com.hk

Tiffany Leung      Tel: (852) 3428 2361   Email: tleung@yuantung.com.hk

HKTDC’s Communications & Public Affairs Department:

Noah Qiu           Tel (852) 2584 4575    Email: noah.yl.qiu@hktdc.org

Navin Law          Tel: (852) 2584 4525   Email: navin.cm.law@hktdc.org

Jane Cheung        Tel: (852) 2584 4137   Email: jane.mh.cheung@hktdc.org

About HKTDC

The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. 

[1] The product was published in the world-leading academic journal Nature Communications (2023).

MUMBAI, INDIA, May 6, 2026 - (ACN Newswire) - KPMG in India and CleverTap today announced a strategic alliance to embed advanced customer engagement capabilities into enterprise transformation programs. The alliance brings together KPMG in India’s Connected Enterprise and advisory capabilities with CleverTap’s customer engagement and retention platform, enabling organisations to explore greater personalisation, while staying aligned with governance, security, and key business priorities.

The alliance will focus on organisations across the BFSI (Banking and Financial Services), retail, and consumer markets. By integrating CleverTap’s analytics and orchestration capabilities into KPMG in India–led initiatives, the alliance is intended to provide organisations with pathways to more effectively connect customer data with execution and to explore more coordinated, lifecycle-based approaches to engagement.

Together, KPMG in India is expected to contribute its consulting experience across operating model design, governance, risk, and compliance, alongside CleverTap’s integrated platform capabilities including  real-time analytics and AI-driven engagement enablement, aimed at supporting organizations in strengthening customer engagement, retention initiatives, and customer lifetime value.

Building on these complementary strengths, the alliance is designed to support companies in their efforts to reduce churn, strengthen customer engagement, and pursue sustainable revenue growth, while also helping them navigate and align with relevant regulatory requirements.

“Our alliance with CleverTap strengthens our ability to help organisations activate insights responsibly and scale customer engagement in a measured, sustainable way. By bringing together our transformation-led consulting approach with CleverTap’s analytics-driven platform, we aim to support companies as they work to deepen customer relationships in a rapidly evolving digital and regulatory environment,” said Ram Seshadri, Partner, Digital Cloud Solutions, KPMG in India.

“Enterprises don’t just need more data; they need intelligence to deliver personalized experiences. By combining KPMG in India’s transformation expertise with our all-in-one customer engagement platform, powered by CleverAI™, we’re equipping brands to deliver true 1:1 personalized journeys that increase customer lifetime value,” said Anand Jain, Co-founder and Chief Marketing Officer, CleverTap.

By combining strategic advisory insights with advanced engagement technology, the alliance aims to help organisations develop stronger, more resilient customer ecosystems for the future.

About KPMG in India

KPMG entities in India, are professional services firm(s). These Indian member firms are affiliated with KPMG International Limited. KPMG was established in India in August 1993. Our professionals leverage the global network of firms, and are conversant with local laws, regulations, markets and competition. KPMG has offices across India in Ahmedabad, Bengaluru, Calicut, Chandigarh, Chennai, Delhi, Gandhinagar, Gurugram, Hyderabad, Jaipur, Kochi, Kolkata, Mumbai, Noida, Pune, Raipur, Trivandrum, Vadodara and Vijayawada.

KPMG entities in India offer services to national and international clients in India across sectors. We strive to provide rapid, performance-based, industry-focussed and technology-enabled services, which reflect a shared knowledge of global and local industries and our experience of the Indian business environment.

About CleverTap

CleverTap is the world’s leading AI-first, all-in-one customer engagement and retention platform, helping brands turn data into lasting customer relationships. Powered by its proprietary CleverAI™: Decisioning Engine and Agentic AI-verse, CleverTap enables organizations to maximize customer lifetime value at scale. Its unified platform brings together AI-powered segmentation, personalization, experimentation, journey orchestration, and deep analytics—seamlessly integrated with 100+ leading martech solutions.

With backing from global investors including Accel, Peak XV Partners, Tiger Global, CDPQ, and 360 One, CleverTap has presence across US, Europe, the Middle East, Latin America, and Asia. Leading brands such as TD Bank, Burger King, Paytm, Levi’s, IKEA, Decathlon, Vodafone, Domino’s, Jio, Carousell, Banco Azteca, Zomato, StockX, and Emirates NBD,  rely on CleverTap to drive measurable growth through meaningful customer engagement.

For more information, visit clevertap.com or follow us on:
LinkedIn: https://www.linkedin.com/company/clevertap/
X: https://twitter.com/CleverTap

Forward-Looking Statements

Some of the statements in this press release may represent KPMG in India’s and CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. Both KPMG in India and CleverTap caution that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.

Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. KPMG in India and CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated or revised status of such statements. Therefore, in no case whatsoever will KPMG in India and  CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.

For more information:

ADITYA SANYAL
Director, Digital Marketing, CleverTap
+91 9177110080
aditya.sanyal@clevertap.com

ASHMIT CHAUDHARY
Associate Consultant, Archetype
+91 8850752121
ashmit.chaudhary@archetype.co

KUALA LUMPUR, Malaysia, April 14, 2026 - (ACN Newswire) - Exito Media Concepts today announced the 46th Edition of the Digital Transformation Summit Malaysia 2026, convening on 23rd April 2026 at the Hyatt Regency Kuala Lumpur Midtown. The summit will bring together more than 200 C-Level executives, technology directors, and government leaders to address the strategic and operational imperatives shaping Malaysia's next phase of digital growth.

Now in its 46th edition and part of a series spanning 11+ countries, the summit has established itself as one of Asia Pacific's most consequential forums for enterprise technology leadership.

The Strategic Context: Malaysia's Digital Economy at a Critical Juncture

Malaysia's digital economy is undergoing a structural shift. Driven by targeted government-led initiatives and accelerating enterprise adoption of artificial intelligence, the Internet of Things, and Web 3.0, organizations across every sector are fundamentally reimagining how they operate, compete, and deliver value.

The opportunity is significant. Yet the path to enterprise-wide transformation demands more than technology investment — it requires navigating complex cybersecurity environments, integrating legacy infrastructure with modern digital architecture, developing organizational capabilities at pace, and embedding a culture of innovation that sustains long-term resilience. For Malaysia's business leadership, strategic clarity has never been more consequential.

The Digital Transformation Summit Malaysia 2026 is designed precisely for this inflection point.

Enterprise Transformation in Practice

The business case for bold digital action is already being written across Malaysia. A leading domestic enterprise recently undertook a comprehensive digital transformation initiative — transitioning to a cloud-first infrastructure supported by advanced data analytics and AI capabilities.

The results were measurable and material: automating key operational processes delivered significant gains in efficiency and organizational agility. The concurrent deployment of robust cybersecurity frameworks ensured data integrity and regulatory compliance. Simultaneously, structured workforce upskilling programmes enabled teams to perform with confidence in an evolving technology environment.

The outcome: improved business performance, deeper customer engagement, and a materially stronger competitive position within Malaysia's digital economy. It is precisely this calibre of real-world insight that the Summit is built to surface and scale.

Event Overview

The 46th Edition of the Digital Transformation Summit Malaysia 2026 is part of a globally recognized series of events hosted across 11+ countries. This edition will convene more than 200 C-Level Executives, Directors, Heads of Technology, Government leaders, and digital transformation leaders from across industries.

Through expert-led keynotes, panel discussions, and real-world case studies, the summit will highlight innovative strategies, emerging technologies, and actionable insights that empower organizations to drive digital growth and operational excellence.

Date: 23rd April 2026
Time: 09:00 AM to 05:00 PM
Venue: Hyatt Regency Kuala Lumpur Midtown
Website: https://digitransformationsummit.com/malaysia/

Summit Agenda: Technology Priorities Shaping 2026

Delivered through expert-led keynotes, high-impact panel discussions, and documented case studies, the Summit agenda will address the technology priorities most consequential to enterprise leaders this year:

Artificial Intelligence & Machine Learning Embedding intelligent decision-making and automation across core business functions — from supply chain to customer experience to financial operations.

Web 3.0 & Emerging Technologies Navigating decentralized innovation and unlocking new digital ecosystems with long-term enterprise relevance.

Internet of Things (IoT) Advancing operational connectivity and efficiency across industries through integrated sensor and data infrastructure.

Quantum Computing Examining the practical and strategic implications of the next frontier in computational capability.

Cybersecurity & Data Protection Strengthening enterprise digital resilience against an increasingly sophisticated and expansive threat landscape.

Cloud & Scalable Infrastructure Building the foundational agility, continuity, and scalability demanded by modern enterprise growth.

Digital Culture & Transformation Strategy Developing the leadership frameworks and organizational behaviours that sustain transformation well beyond initial implementation.

Data-Driven Decision Making Harnessing analytics to convert raw data into competitive intelligence and measurable business outcomes.

About Exito Media Concepts

Exito — the word for success — is both the name and the operating philosophy of one of the world's most active B2B events and media organizations. Over 16 years, Exito has built a reputation for delivering 240+ conferences annually across technology, digital transformation, cybersecurity, healthcare, and emerging enterprise sectors worldwide.

Every Exito event is defined by meticulous agenda curation, access to world-class speaker communities, and a commitment to market-driven insight that translates directly into strategic value for attendees, sponsors, and partners. The result is a global platform trusted by thousands of senior executives to inform their most consequential decisions.

Media Contact
Prakruthi Nayaka
Media and PR Executive, Exito Media Concepts
Email: prakruthi.nayaka@exito-e.com
Website: https://digitransformationsummit.com/malaysia/ 

HONG KONG, Apr 2, 2026 - (ACN Newswire) - Shoucheng Holdings’ (0697.HK) investments in the robotics sector are moving from early-stage positioning toward value realization.

Management has disclosed that, by the end of 2025, the Company—through multiple industry funds under its management—had cumulatively invested more than RMB 2 billion across the broader robotics industry chain, covering more than 20 companies. According to the Chairman’s Statement for 2025, the valuation of the investment portfolio of the Beijing Robot Industry Development Investment Fund (Limited Partnership) increased by approximately fourfold. On that basis, the corresponding unrealized book gain is estimated at around RMB 8 billion. The robotics business has therefore become one of the most closely watched sources of incremental upside for Shoucheng Holdings in the near term.

Based on disclosed projects, Shoucheng Holdings’ robotics strategy is not a series of isolated bets, but rather a systematic deployment across the industry chain. In the field of embodied intelligence and robotics, the Company has made concentrated investments in more than 20 leading companies, including Unitree Robotics, Noetix Robotics, Galbot, DEEP Robotics, Booster Robotics, and Galaxea AI. In the latest Chairman’s Statement, Chairman Zhao Tianyang characterized this approach as “track-level deployment”.

Unlike some purely financial investors, Shoucheng Holdings is advancing its robotics business from simply “holding equity stakes” to “operating an industry”. Following an integrated path of “investment + operations + ecosystem,” the Company is building capabilities centered on “funds + scenarios + industry chain,” providing robotics companies with capital support, application scenarios, supply-chain integration, and commercialization pathways. On the offline channel side, its robotics consumer experience brand, Taozhu New Creation, has established five stores in Beijing, with locations including Shougang Park, Beijing Capital International Airport Terminals 2 and 3, and Wangfujing APM, among other core venues. To date, the Company has signed agreements with nearly 100 robotics companies as authorized agents.

Market analysts note that the valuation logic for Shoucheng Holdings’ robotics business is transitioning from book valuations in the primary market toward more observable pricing in the capital markets. As a representative investment within Shoucheng Holdings’ robotics portfolio, Unitree Robotics—together with its IPO progress—provides the market with a clearer anchor for assessing the value of Shoucheng Holdings’ robotics assets.

From a longer-term perspective, the data points of “more than RMB 2 billion invested, more than 20 companies covered, and portfolio valuation increasing approximately fourfold to around RMB 8 billion” already outline the basic contours of Shoucheng Holdings’ robotics strategy:At the front end, the Company secures leading projects through its funds.In the mid-stage, it accelerates commercialization through channels and service systems.At the back end, it opens up exit and re-rating opportunities through IPOs and capital operations.

As projects such as Unitree Robotics move into the capital-market spotlight, the book value of Shoucheng Holdings’ robotics investments, its industrial synergy capabilities, and its subsequent monetization path are becoming increasingly clear.

BANGKOK, Apr 1, 2026 - (ACN Newswire) - True Internet Data Center Co., Ltd. (True IDC), Thailand’s largest data center and cloud service provider under Charoen Pokphand Group, has announced the development of a new mega data center in a strategic location within the Eastern Economic Corridor (EEC). As one of several major projects approved under a Board of Investment (BOI) promotion totaling over 77 billion THB, this mega-project aims to drive the “Security Economy,” strengthen Data Sovereignty, and elevate Thailand’s competitiveness in the fully realized digital and AI era.The first phase is scheduled to be operational by 2027.

Specifically engineered to support the exponential growth of cloud, digital, and AI systems, the new AI Hyperscale facility will boast a total power capacity of up to 250 MW. It features a fully modular architecture and a ready platform play strategy, enabling faster construction, seamless system deployment, and a quicker speed-to-market service delivery than ever before.

In developing this site, True IDC is leveraging its deep expertise in serving global hyperscalers from both the US and China. This includes applying its unique experience as the first provider in Thailand capable of hosting advanced GPU processing systems for AI. Furthermore, the facility introduces a cutting-edge power architecture designed to enhance electrical efficiency and minimize operational and maintenance risks. This focus on uncompromised business continuity is balanced with sustainable energy management, targeting a best-in-class Power Usage Effectiveness (PUE) level.

Thanasorn Jaidee

Mr. Thanasorn Jaidee, President of True IDC, noted that according to Krungsri Research (2026–2028), revenue from digital services and software is expected to grow at an average annual rate of 6.8%, naturally driving the demand for advanced digital infrastructure. "As the leading data center and cloud service provider for 23 years, True IDC recognizes that organizations still require digital infrastructure that delivers speed," Mr. Thanasorn stated. "However, in today’s world, agility alone is not enough; it must be coupled with proactive security in every situation.We are committed to making this data center a vital engine in driving the Security Economy alongside the Digital Economy—creating technological independence, protecting critical national data, and ensuring that both public and private sector systems can operate without interruption."

About True IDC

True Internet Data Center Co., Ltd. (Headquarters: Bangkok, Thailand), operating under the Charoen Pokphand Group in a global partnership with GIP-BlackRock, is the largest data center service provider in Thailand. The company stands out with its AI Hyperscale Data Center services, designed specifically for advanced computing and the rapid expansion of cloud and Artificial Intelligence (AI) systems. Backed by extensive experience managing data centers in key business districts both locally and internationally—and certified to the highest global standards—True IDC is fully equipped to meet the demands and enhance the security of businesses in the digital age. Trusted by world-leading organizations, True IDC serves as a vital mechanism in propelling the digital economies of Thailand and the broader ASEAN region toward a strong, resilient future.

More Information: https://www.trueidc.com/

For more information, visit:
Email: suchitra@888ideas.com

Extreme Vision, based in Qingdao, Shandong, has delivered its answer through a compelling set of metrics. As of September 30, 2025, the Company had completed over 6,000 projects, recorded a product repurchase rate exceeding 80%, and served more than 100 industries, including manufacturing, energy, retail, and transportation. Revenue grew from RMB101.6 million in 2022 to RMB257.3 million in 2024, representing a compound annual growth rate of 59.2%. The Company turned profitable in 2024.

A Platform-based Approach to Tackling the Fragmentation Challenge

Extreme Vision was founded by three entrepreneurs born in the 1990s: Mr. Chan Chan Kit, Ms. Luo Yun, and Mr. Chen Shuo. Mr. Chan Chan Kit holds a direct stake of 16.05% in the Company and serves as its largest shareholder, legal representative, chairman of the board, executive director, and general manager. The three founders, all alumni of Sun Yat-sen University, first conceived the idea of starting a business during their undergraduate studies.

“The biggest challenge in the B2B market is fragmentation,” Mr. Chan once noted. Different industries, different enterprises, and even different production processes within the same company all have vastly different AI requirements. If each scenario requires developing algorithms from scratch, the cost is prohibitive, the timeline is protracted, and scaling becomes virtually impossible. This is precisely the “B2B chasm” that many AI companies struggle to cross. Based on this insight, Extreme Vision pioneered the AI Vision Algorithm Marketplace.

As of September 30, 2025, Extreme Vision’s algorithm marketplace has launched 1,517 algorithms, including 1,369 algorithms co-developed with third-party developers. Covering application scenarios in over 100 industries, the platform has served more than 3,000 customers and delivered over 6,000 projects since its establishment. Notably, the product repurchase rate has exceeded 80%, reflecting the strong standardization of its solutions and robust market recognition.

Self-developed AI infrastructure empowers efficient implementation. The Company’s self-developed AI infrastructure enables efficient algorithm development and rapid solution development. On the one hand, leveraging its self-developed full-stack technology platform, Extreme Vision has built an industry-leading AI infrastructure that covers the entire lifecycle, including data annotation, model training, algorithm development, algorithm testing and inference deployment. On the other hand, the integrated tool engines within its AI development infrastructure significantly lowering the barriers to algorithm development and drastically reducing the time required for customized algorithm development.

Multi-industry Implementation: Project Practice as a Driver for Healthy Growth

Leveraging its platform-based capabilities, Extreme Vision has applied its technology to real-world business scenarios across various sectors, delivering actionable and reusable solutions.

In terms of industrial manufacturing, Extreme Vision deployed an EHS+AI intelligent monitoring system for CR Beer. By implementing 25 categories of risk-identification algorithms, the system accurately captures risk scenarios such as the improper wearing of safety ropes and goggles, hoisting operations, and unauthorized personnel intrusion during equipment operation. This has successfully transformed traditional passive safety management into proactive, real-time, and automated risk control.

In terms of environmental and energy sectors, Extreme Vision has built an intelligent security management platform, “Halo Guard” for China Everbright Environmental Energy. Equipped with nearly 30 AI vision algorithms for safety management and control, the platform conducts real-time monitoring of high-risk operational scenarios such as unloading platforms and burning zones, significantly enhancing operational safety.

In the higher education sector, Extreme Vision has jointly established the “Artificial Intelligence Comprehensive Practice Center” with the School of Smart City at Beijing Union University. Leveraging its Extreme Flow platform, the Company supports algorithm teaching and research in universities, helping to cultivate AI talent.

In the transportation and mobility sector, Extreme Vision has identified new application scenarios for large model solutions. Using large model technologies, the Company has generated autonomous driving simulation scenario data and conducted hallucination detection for a leading automotive retailer, helping the client reduce reliance on real-world road data collection and optimize the R&D process.

These projects not only demonstrate the breadth and depth of Extreme Vision's technology implementation but also collectively underpin the Company's sustained growth. Each successfully delivered project generates experience and reusable modules for future projects, creating a virtuous cycle that contributes to a product repurchase rate of over 80%.

Profitability Continuously Validated, Large Model Emerges as a New Growth Driver

As its commercial value continues to be validated, Extreme Vision's profitability has also shown strong growth momentum. The Company's revenue grew from RMB101.6 million in 2022 to RMB257.3 million in 2024, representing a compound annual growth rate (CAGR) of 59.2%. The gross profit margin improved from 30.6% in 2022 to 40.2% in 2024. The Company recorded a profit of RMB8.71 million in 2024, making it one of the few profitable AI vision companies in China. For the nine months ended September 30, 2025, the Company achieved revenue of RMB136.3 million, a year-on-year increase of 71.7%, with the gross profit margin further rising to 44.9%.

Notably, the large model solutions launched by the Company in 2024 contributed RMB62.12 million in revenue, accounting for 24.1% of total revenue. This has become a new growth driver and is expected to unlock further market opportunities.

In terms of R&D investment, the Company continued to increase its efforts. R&D expenditure reached RMB44.82 million in 2024, an increase of 22.6% compared to 2023. As of September 30, 2025, the Company had a professional team of 101 R&D personnel. According to the Prospectus, the Company intends to use approximately 60.0% of the net proceeds from the IPO (HK$260.6 million) to enhance R&D capabilities, including the construction of large models and AI infrastructure, as well as the upgrade of AI-PaaS middleware.

Broad Market Prospects: The Platform Flywheel Accelerates

Industry prospects are promising. According to Frost & Sullivan, the market size of China’s emerging enterprise-level computer vision solutions is projected to grow from RMB11.1 billion in 2024 to RMB97.0 billion in 2029, representing a CAGR of 54.3%. This represents an almost eightfold increase in market size over the next five years, indicating strong inherent growth potential in the sector.

As large models gain traction globally, market expectations for AI have been further elevated. However, in the B2B market, no matter how cutting-edge the technology is, it must ultimately return to the simple logic of “usability, practicality, and cost controllability.” Extreme Vision's experience shows that a competitive edge for AI companies lies not only in technological leadership but also in the ability to develop standardized solutions for complex industrial scenarios and scale them through platforms and ecosystems.

From algorithms to applications, from project delivery to customer retention, Extreme Vision has remained committed to its mission of pushing technological boundaries and harnessing technology for good—building an AI flywheel that continuously generates commercial value. As AI technology permeates all industries, from industrial safety and energy inspection to retail operations, the demand for fragmented long-tail scenarios continues to emerge, positioning Extreme Vision for accelerated growth. However, whether it can continuously increase market share and improve cash flow amid fierce competition remains a core challenge post-listing.

HONG KONG, Mar 27, 2026 - (ACN Newswire) - In the Hong Kong stock market, the key to consistently winning investor trust lies not just in periodic earnings growth, but in the ability to stably transform operating results into shareholder returns. According to the latest 2025 annual results report disclosed by Shoucheng Holdings (0697.HK), the company proposes a dividend of 780 million HKD, corresponding to an average annual market value dividend yield of approximately 5.6%. Looking at the long term, since its strategic transformation in 2018, the company has continuously advanced business transformation and structural optimization, leading to steady improvements in profitability and cash flow quality. It has maintained stable dividends for many consecutive years, with a cumulative dividend scale of approximately 6 billion HKD over eight years, shifting the investment logic from "growth expectations" toward "balancing both growth and returns".

It is noteworthy that this dividend does not rely on high leverage or short-term overdrafts; rather, it is a proactive return built on improved balance sheets, enhanced operating quality, and optimized cash flow. As of December 31, 2025, the company's bank balances and cash stood at 3.671 billion HKD, with total borrowings of 979 million HKD. The cash-to-interest-bearing debt coverage ratio is approximately 3.75 times, demonstrating strong dividend sustainability and a significant financial safety margin.

Over the past eight years, Shoucheng Holdings has gradually formed a smart infrastructure asset service system centered on parking asset management, industrial space management, REITs investment, and equity investment, constructing a composite model of "operational efficiency + asset management + capital circulation". Mature businesses such as parking and industrial parks continue to provide steady cash flow, serving as the practical foundation for the company's dividends. Meanwhile, REITs investments, the robotics ecosystem, and emerging industry funds further open up space for profit realization and valuation enhancement.

Among these, the robotics business is becoming a significant incremental driver of Shoucheng Holdings' long-term value. In recent years, the company has continuously refined its robotics layout around "investment + operations + ecosystem," systematically investing in several leading robotics enterprises. Through scenario integration, channel construction, and industrial services, it has pushed projects from technical verification to commercial implementation. As relevant companies accelerate financing, see valuation increases, or move toward IPOs, the robotics segment is expected to continuously strengthen the company's mid-to-long-term profit release and shareholder return capabilities.

Furthermore, in the latest Chairman's Statement, Chairman Zhao Tianyang explicitly expressed "gratitude" to investors and continued to emphasize "creating long-term value for investors". This statement is not merely a declaration of attitude but sends a clear signal: Shoucheng Holdings is placing shareholder returns and long-termism in a more prominent position. For the market, the significance of eight years of continuous dividends has long transcended a simple profit distribution; it serves as a more certain anchor of confidence for long-term capital amidst complex economic cycles.